Spain (ES)

Phase II neoadjuvant study of GDC-9545+palbociclib (palbo) vs anastrozole (A) plus palbo in postmenopausal women with estrogen receptor-positive, HER2-negative, untreated early breast cancer (ER+/HER2-eBC) (2021) Hurvitz SA, Fasching P, Park YH, Quiroga V, Crnjevic TB, Fresco R, Lopez-Valverde V, et al. Conference contribution Response to Escande et al.: Magnetic guided brachytherapy: Time for non-pelvic cancer? Example from tongue brachytherapy [1] (2021) Kovács G, Martinez-Monge R, Budrukkar A, Guinot JL, Johansson B, Strnad V, Rovirosa A, et al. Journal article Advanced small intestine well-differentiated neuroendocrine tumors (WD-SiNET): A survey of practice on 3rd line treatment (2021) Lamarca A, Cives M, De Mestier L, Crona J, Spada F, Oberg K, Pavel ME, Alonso-Gordoa T Conference contribution Nonclassical nucleation-role of metastable intermediate phase in crystal nucleation: An editorial prefix (2021) Zhang F, Gavira JA, Lee GW, Zahn D Journal article Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia (2021) Trpkov K, Williamson SR, Gill AJ, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, et al. Journal article Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era (2021) Rodriguez-Freixinos V, Capdevila J, Pavel ME, Thawer A, Baudin E, O'Toole D, Herrmann K, et al. Journal article, Review article Constraining the contribution of Gamma-Ray Bursts to the high-energy diffuse neutrino flux with 10 yr of ANTARES data (2021) Albert A, Andre M, Anghinolfi M, Anton G, Ardid M, Aubert JJ, Aublin J, et al. Journal article Modelling X-ray RMS spectra II: the ultrafast outflow of PDS 456 (2021) Härer L, Parker ML, Joyce A, Igo Z, Alston WN, Furst F, Lobban AP, et al. Journal article An exciting twenty-year journey exploring porphyrinoid-based photo- and electro-active systems (2021) Bottari G, de la Torre G, Guldi DM, Torres T Journal article, Review article Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer A Phase 3 Randomized Clinical Trial (2021) Rugo HS, Im SA, Cardoso F, Cortes J, Curigliano G, Musolino A, Pegram MD, et al. Journal article